HLA-matched
Showing 1 - 25 of 4,627
Severe Aplastic Anemia Trial (Busulfan, Flu/Cy/ATG or Cy/ATG)
Not yet recruiting
- Severe Aplastic Anemia
- Busulfan
- Flu/Cy/ATG or Cy/ATG
- (no location specified)
Oct 1, 2023
Assess 7/8 HLA-matched Hematopoietic Stem Cell Transplantation
Completed
- Stem Cell Transplantation
-
Princeton, New JerseyLocal Institution
Jun 13, 2022
Viral Infections After HSCT Trial in Washington (VSTs)
Active, not recruiting
- Viral Infections After HSCT
- VSTs
-
Washington, District of ColumbiaChildrens National Medical Center
Aug 30, 2022
Myeloid Malignancies, Lymphoid Malignancies Trial in Durham (NK Cell enriched-DLI only, NK-DLI + DUK-CPG-001)
Recruiting
- Myeloid Malignancies
- Lymphoid Malignancies
- NK Cell enriched-DLI only
- NK-DLI + DUK-CPG-001
-
Durham, North CarolinaDuke University Health System
Mar 8, 2022
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia Trial in Duarte, Atlanta (procedure, drug,
Not yet recruiting
- Acute Lymphoblastic Leukemia
- +9 more
- Allogeneic Hematopoietic Stem Cell Transplantation
- +7 more
-
Duarte, California
- +1 more
Sep 22, 2023
Hematological Malignancies Trial in Belgium, Netherlands (Conditioning regimen: TBI + Fludarabine, Conditioning regimen:TLI (8
Completed
- Hematological Malignancies
- Conditioning regimen: TBI + Fludarabine
- Conditioning regimen:TLI (8 Gy) + ATG
-
Leuven, Flamish Brabant, Belgium
- +10 more
Nov 16, 2021
Kidney Transplant Rejection Trial in Canada, United States (MDR-101)
Active, not recruiting
- Kidney Transplant Rejection
- MDR-101
-
La Jolla, California
- +19 more
Aug 22, 2022
Sickle Cell Disease, Hemoglobinopathies Trial in Nashville (drug, procedure, radiation)
Active, not recruiting
- Sickle Cell Disease
- Hemoglobinopathies
- Thymoglobulin
- +7 more
-
Nashville, TennesseeVanderbilt-Ingram Cancer Center
Dec 20, 2021
GVHD, Hematological Malignancies Trial in Belgium (Mycophenolate mofetil, Sirolimus)
Active, not recruiting
- Graft-Versus-Host Disease
- Hematological Malignancies
- Mycophenolate mofetil
- Sirolimus
-
Antwerpen,, Antwerpen, Belgium
- +12 more
Mar 22, 2022
Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor, Symptomatic COVID-19 Infection Laboratory-Confirmed Trial in
Recruiting
- Hematopoietic and Lymphoid Cell Neoplasm
- +2 more
- SARS-CoV-2 Antigen-specific Cytotoxic T-lymphocytes
-
Houston, TexasM D Anderson Cancer Center
Jul 13, 2022
Acute Leukemia, Acute Lymphocytic Leukemia, Acute Myelogenic Leukemia Trial (Haploidentical hematopoietic cell transplantation
Not yet recruiting
- Acute Leukemia
- +4 more
- Haploidentical hematopoietic cell transplantation (haploHCT)
- matched unrelated donor hematopoietic cell transplantation (MUD-HCT)
- (no location specified)
Jul 13, 2022
Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in New Hyde Park (radiation, drug,
Completed
- Acute Lymphoblastic Leukemia
- +5 more
- Radiation
- +3 more
-
New Hyde Park, New YorkCohen Children's Medical Center
Apr 6, 2022
Acute Myeloid Leukemia in Remission, MDS, Chronic Myeloid Leukemia in Remission Trial in Belgium (Thymoglobulin, Melphalan,
Recruiting
- Acute Myeloid Leukemia in Remission
- +9 more
- Thymoglobulin
- +3 more
-
Antwerp, Belgium
- +9 more
Oct 5, 2021
Acute Myeloid Leukemia, Advanced MDS Trial in New York (Busulfan, Melphalan, Fludarabine, Anti-Thymocyte Globulin, Palifermin,
Completed
- Acute Myeloid Leukemia
- Advanced Myelodysplastic Syndromes
- Busulfan, Melphalan, Fludarabine, Anti-Thymocyte Globulin, Palifermin, Stem cell transplant
-
New York, New YorkMemorial Sloan-Kettering Cancer Center
Aug 27, 2021
Primary Immunodeficiency, PID Trial in Pittsburgh (CD3/CD19 neg allogeneic BMT)
Active, not recruiting
- Primary Immunodeficiency
- PID
- CD3/CD19 neg allogeneic BMT
-
Pittsburgh, PennsylvaniaChildren's Hospital of Pittsburgh of University of Pittsburgh Me
Oct 6, 2021
Multiple Myeloma, Amyloidosis Trial in Boston (drug, procedure, radiation)
Completed
- Multiple Myeloma
- Amyloidosis
- Tacrolimus
- +4 more
-
Boston, MassachusettsMassachusetts General Hospital
Aug 24, 2021
Immune Tolerance Trial in Stanford (Hematopoietic cell transplantation, Total lymphoid irradiation)
Active, not recruiting
- Immune Tolerance
- Hematopoietic cell transplantation
- Total lymphoid irradiation
-
Stanford, CaliforniaStanford University, School of Medicine
Jun 15, 2021
Severe Combined Immunodeficiency (SCID), Immunodeficiency With Predominant T-cell Defect, Unspecified, Severe Chronic
Enrolling by invitation
- Severe Combined Immunodeficiency (SCID)
- +8 more
- CD3/CD19 negative allogeneic hematopoietic stem cells
-
Pittsburgh, PennsylvaniaChildren's Hospital of Pittsburgh of UPMC
Dec 6, 2021
Hematologic Malignancies Trial in Lebanon (Stem Cell Transplant, G-CSF, Fludarabine)
Completed
- Hematologic Malignancies
- Stem Cell Transplant
- +5 more
-
Lebanon, New HampshireDartmouth-Hitchcock Medical Center
Oct 30, 2020
Severe Aplastic Anemia, Bone Marrow Failure Syndromes Trial in Baltimore, Milwaukee (procedure, drug, radiation)
Completed
- Severe Aplastic Anemia
- Bone Marrow Failure Syndromes
- Bone marrow transplant
- +7 more
-
Baltimore, Maryland
- +1 more
Feb 10, 2022
Hematologic Tumors Trial run by the NCI (Stem cell transplantation, Fludarabine, Cyclophosphamide)
Completed
- Hematologic Neoplasms
- Stem cell transplantation
- +9 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 19, 2021
Myeloid Malignancies Trial in Italy (GvHD prophylaxis)
Recruiting
- Myeloid Malignancies
- GvHD prophylaxis
-
Alessandria, Italy
- +32 more
Nov 23, 2022